VKH
ALBO

Virtu KCG Holdings’s Albireo Pharma Inc ALBO Stock Holding History

Virtu KCG Holdings’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-408
Closed -$5K – 3913
2016
Q3 		$5K Sell
408
-1,885
-82% -$22.2K ﹤0.01% 3005
2016
Q2 		$21K Buy
2,293
+1,485
+184% +$16.4K ﹤0.01% 2795
2016
Q1 		$8K Sell
808
-233
-22% -$2.07K ﹤0.01% 2664
2015
Q4 		$11K Buy
1,041
+274
+36% +$2.83K ﹤0.01% 3364
2015
Q3 		$10K Buy
767
+368
+92% +$9.27K ﹤0.01% 3227
2015
Q2 		$12K Sell
399
-408
-51% -$13.7K ﹤0.01% 3224
2015
Q1 		$29K Buy
+807
New +$34K ﹤0.01% 2908

Other funds holding ALBO

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
PVH
Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CG
Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return

Virtu KCG Holdings's ALBO Position: Q4 2016 in Review

Virtu KCG Holdings sold out of Albireo Pharma Inc (ALBO) in Q4 2016, closing a stake of 408 shares — an estimated $5K sold.

Virtu KCG Holdings first reported a position in ALBO in Q1 2015 and held it in 7 quarters. The position peaked at $29K in Q1 2015. 19 funds tracked by Wall St. Rank hold ALBO as of Q4 2016.

  • Virtu KCG Holdings reported no remaining Albireo Pharma Inc position as of Q4 2016 after selling out during the quarter.
  • Virtu KCG Holdings sold 408 Albireo Pharma Inc shares in Q4 2016, an estimated $5K.
  • Virtu KCG Holdings first reported a position in Albireo Pharma Inc in Q1 2015 and held it in 7 quarters.
  • Virtu KCG Holdings's Albireo Pharma Inc position peaked at $29K in Q1 2015.
  • 19 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q4 2016.

Based on Virtu KCG Holdings's 13F filing for Q4 2016, filed 10 Feb 2017.